Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Rosa Nguyen

Showing results (31-40 of 51) with videos related to

Pageof 6
Sort By:
Plos One|May 5, 2012
Quantitative assessment of whole-body tumor burden in adult patients with neurofibromatosisScott R Plotkin, Miriam A Bredella, Wenli Cai, et al.
BMC Medicine|July 6, 2011
MIA is a potential biomarker for tumour load in neurofibromatosis type 1Mateusz Kolanczyk, Victor Mautner, Nadine Kossler, et al.
The EMBO Journal|August 22, 2024
Targeting SWI/SNF ATPases reduces neuroblastoma cell plasticityMan Xu, Jason J Hong, Xiyuan Zhang, et al.
Pediatric Blood & Cancer|May 18, 2016
The Role of Leukapheresis in the Current Management of Hyperleukocytosis in Newly Diagnosed Childhood Acute Lymphoblastic LeukemiaRosa Nguyen, Sima Jeha, Yinmei Zhou, et al.
Cancer Immunology Research|June 26, 2025
GPC2-Targeted CAR T Cells Engineered with NFAT-Inducible Membrane-Tethered IL15/IL21 Exhibit Enhanced Activity against NeuroblastomaReona Okada, Jeyshka M Reyes-González, Constanza Rodriguez, et al.
Journal for Immunotherapy of Cancer|March 22, 2019
A phase II clinical trial of adoptive transfer of haploidentical natural killer cells for consolidation therapy of pediatric acute myeloid leukemiaRosa Nguyen, Huiyun Wu, Stanley Pounds, et al.
Molecular Therapy. Oncology|October 29, 2025
GPC2-CAR T cells have potent preclinical activity against orthotopic medulloblastoma xenograftsReona Okada, Mia Fanuzzi, Constanza Rodriguez, et al.
Journal for Immunotherapy of Cancer|March 30, 2020
Longitudinal NK cell kinetics and cytotoxicity in children with neuroblastoma enrolled in a clinical phase II trialRosa Nguyen, Natasha Sahr, April Sykes, et al.
Cell Reports. Medicine|September 30, 2025
Antibody-gamma/delta T cell receptors targeting GPC2 regress neuroblastoma with low antigen densityAlex Quan, Mingyu Huo, Dan Li, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 1, 2023
Cooperative Armoring of CAR and TCR T Cells by T Cell-Restricted IL15 and IL21 Universally Enhances Solid Tumor EfficacyRosa Nguyen, Ekaterina Doubrovina, Charlotte M Mousset, et al.
Pageof 6

Showing results (31-40 of 51) with videos related to

Sort By:
Pageof 6
Plos One|May 5, 2012
Quantitative assessment of whole-body tumor burden in adult patients with neurofibromatosisScott R Plotkin, Miriam A Bredella, Wenli Cai, et al.
BMC Medicine|July 6, 2011
MIA is a potential biomarker for tumour load in neurofibromatosis type 1Mateusz Kolanczyk, Victor Mautner, Nadine Kossler, et al.
The EMBO Journal|August 22, 2024
Targeting SWI/SNF ATPases reduces neuroblastoma cell plasticityMan Xu, Jason J Hong, Xiyuan Zhang, et al.
Pediatric Blood & Cancer|May 18, 2016
The Role of Leukapheresis in the Current Management of Hyperleukocytosis in Newly Diagnosed Childhood Acute Lymphoblastic LeukemiaRosa Nguyen, Sima Jeha, Yinmei Zhou, et al.
Cancer Immunology Research|June 26, 2025
GPC2-Targeted CAR T Cells Engineered with NFAT-Inducible Membrane-Tethered IL15/IL21 Exhibit Enhanced Activity against NeuroblastomaReona Okada, Jeyshka M Reyes-González, Constanza Rodriguez, et al.
Journal for Immunotherapy of Cancer|March 22, 2019
A phase II clinical trial of adoptive transfer of haploidentical natural killer cells for consolidation therapy of pediatric acute myeloid leukemiaRosa Nguyen, Huiyun Wu, Stanley Pounds, et al.
Molecular Therapy. Oncology|October 29, 2025
GPC2-CAR T cells have potent preclinical activity against orthotopic medulloblastoma xenograftsReona Okada, Mia Fanuzzi, Constanza Rodriguez, et al.
Journal for Immunotherapy of Cancer|March 30, 2020
Longitudinal NK cell kinetics and cytotoxicity in children with neuroblastoma enrolled in a clinical phase II trialRosa Nguyen, Natasha Sahr, April Sykes, et al.
Cell Reports. Medicine|September 30, 2025
Antibody-gamma/delta T cell receptors targeting GPC2 regress neuroblastoma with low antigen densityAlex Quan, Mingyu Huo, Dan Li, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 1, 2023
Cooperative Armoring of CAR and TCR T Cells by T Cell-Restricted IL15 and IL21 Universally Enhances Solid Tumor EfficacyRosa Nguyen, Ekaterina Doubrovina, Charlotte M Mousset, et al.
Pageof 6